These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15565637)
1. Thalidomide for advanced hepatocellular carcinoma: is this a real alternative? Wadler S Cancer; 2005 Jan; 103(1):1-4. PubMed ID: 15565637 [No Abstract] [Full Text] [Related]
3. Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope? Cipriani G; Mazzanti R Dig Liver Dis; 2005 Apr; 37(4):230-1. PubMed ID: 15788205 [No Abstract] [Full Text] [Related]
4. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. Pinter M; Wichlas M; Schmid K; Plank C; Müller C; Wrba F; Peck-Radosavljevic M Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1012-9. PubMed ID: 18787470 [TBL] [Abstract][Full Text] [Related]
5. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma. Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834 [TBL] [Abstract][Full Text] [Related]
15. Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma. Chuah B; Lim R; Boyer M; Ong AB; Wong SW; Kong HL; Millward M; Clarke S; Goh BC Acta Oncol; 2007; 46(2):234-8. PubMed ID: 17453375 [TBL] [Abstract][Full Text] [Related]
16. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209 [TBL] [Abstract][Full Text] [Related]
17. Successful targeted therapies for hepatocellular carcinoma: are we really getting there? Zhu AX Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516 [No Abstract] [Full Text] [Related]
18. Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy. Demeria D; Birchall I; Bain VG Can J Gastroenterol; 2007 Aug; 21(8):517-8. PubMed ID: 17703252 [No Abstract] [Full Text] [Related]
19. Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial. Patt YZ; Hassan MM; Lozano RD; Nooka AK; Schnirer II; Zeldis JB; Abbruzzese JL; Brown TD Cancer; 2005 Feb; 103(4):749-55. PubMed ID: 15660400 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide-induced severe facial erythema in a patient with hepatocellular carcinoma. Chiou CC; Shih IH; Chang YC; Lee JC; Kuo SC; Hong HS; Yang CH Int J Clin Pract; 2007 Aug; 61(8):1415-7. PubMed ID: 17627717 [No Abstract] [Full Text] [Related] [Next] [New Search]